gvtcx

Recombinant Von Willebrand Factor

NHS England Published 22 Feb 2021 Contracts Finder

key details

Value£250,000
Statuscomplete
Category (CPV) 33600000
Deadline7 Dec 2020
Contract start1 Feb 2021
Contract end30 Jun 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-73c7f75a-2d95-4205-9a33-0607288e1383

Award

SupplierValueDateStatus
Shire Pharmaceuticals Ltd £250,000 12 Jan 2021 active

description

NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
25 Nov 2020 Tender (tender) · 7467c24f-3b2e-438f-a22c-ba698c6be83e-395870
22 Feb 2021 Award (award) · 6fd67351-d9aa-4d0d-9897-4773f8c61faf-414817

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.